Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Newborn screening and its relationship to the diagnosis and treatment of the disorder
- 30 June 1993
- Vol. 2 (2-3), 105-139
- https://doi.org/10.1016/0925-6164(93)90024-d
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Regulation of the hypothalamic–pituitary–adrenal axis in birthCanadian Journal of Physiology and Pharmacology, 1988
- Relationship between maternal and fetal corticotrophin-releasing hormone-41 and ACTH levels in human mid-trimester pregnancyJournal of Endocrinology, 1987
- HLA typing used with cultured amniotic and chorionic villus cells for early prenatal diagnosis or parentage testing without one parent's availabilityHuman Immunology, 1986
- Gene Conversion in Salt-Losing Congenital Adrenal Hyperplasia with Absent Complement C4B Protein*Journal of Clinical Endocrinology & Metabolism, 1986
- Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalamiJournal of Endocrinology, 1986
- Prenatal treatment of congenital adrenal hyperplasia resulting from 21-hydroxylase deficiencyThe Journal of Pediatrics, 1984
- Neonatal Screening for Congenital Adrenal Hyperplasia Using a Microfilter Paper Method for 17-α-Hydroxyprogesterone RadioimmunoassayHormone Research, 1982
- CLOSE GENETIC LINKAGE BETWEEN HLA AND CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY)The Lancet, 1977
- The Prepuberal and Puberal Growth of the Adrenal (Adrenarche)Beiträge zur Pathologie, 1973
- The Adrenogenital SyndromeNew England Journal of Medicine, 1963